Barclays Initiates Coverage of Ligand Pharmaceuticals Incorporated - Equity Right at Overweight
Published . Updated .
Fintel reports that on September 25, 2026, Barclays initiated coverage of Ligand Pharmaceuticals Incorporated - Equity Right (OTCPK:LGNDZ) with a Overweight recommendation. This analyst action is accompanied by other recent updates from various firms. On September 24, 2026, HC Wa
Directly affected
Indirectly affected
- DXJ WISDOMTREE JAPAN HEDGED EQUITY FD ETF
GA selected DXJ as a RELATED security because its canonical security name directly matches this event's themes: equity. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- AIEQ AMPLIFY AI POWERED EQUITY ETF
GA selected AIEQ as a RELATED security because its canonical security name directly matches this event's themes: equity. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- AIOO ALLIANZIM U.S. EQUITY BUFFER100 PROTECTION ETF
GA selected AIOO as a RELATED security because its canonical security name directly matches this event's themes: equity. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- AJUL INNOVATOR EQUITY DEFINED PROTECTION ETF - 2 YR TO JULY 2026
GA selected AJUL as a RELATED security because its canonical security name directly matches this event's themes: equity. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- AVMC AMERICAN CENTY ETF TR AVANTIS U S MID CAP EQUITY ETF
GA selected AVMC as a RELATED security because its canonical security name directly matches this event's themes: equity. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BJUL INNOVATOR U.S. EQUITY BUFFER ETF - JULY
GA selected BJUL as a RELATED security because its canonical security name directly matches this event's themes: equity. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Fintel reports that on September 25, 2026, Barclays initiated coverage of Ligand Pharmaceuticals Incorporated - Equity Right (OTCPK:LGNDZ) with a Overweight recommendation. This analyst action is accompanied by other recent updates from va…
Source: Nasdaq Markets
The price since 25 Sep 2026: Barclays (BCS) versus the S&P 500
Since the first closing price after “Barclays Initiates Coverage of Ligand Pharmaceuticals Incorporated - Equity Right at Overweight,” Barclays (BCS) is -9.88%. The S&P 500 fund (SPY) is +0.15% over the same days, a -10.02% difference versus the market.
Who gains and who loses around Barclays (BCS)
Companies mentioned with this story
- BCS Barclays
For “Barclays Initiates Coverage of Ligand Pharmaceuticals Incorporated - Equity Right at Overweight,” Barclays (BCS) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names BARCLAYS PLC in the headline; GA resolved that company to BCS
- DXJ Wisdomtree Japan Hedged Equity Fd Etf
In “Barclays Initiates Coverage of Ligand Pharmaceuticals Incorporated - Equity Right at Overweight,” Wisdomtree Japan Hedged Equity Fd Etf (DXJ) is linked, with no stored direction, medium confidence. Reason on file: GA selected DXJ as a RELATED security because its canonical security name directly matches this event's themes: equity. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- AIEQ Amplify Ai Powered Equity Etf
For “Barclays Initiates Coverage of Ligand Pharmaceuticals Incorporated - Equity Right at Overweight,” Amplify Ai Powered Equity Etf (AIEQ) is linked, with no stored direction, medium confidence. Reason on file: GA selected AIEQ as a RELATED security because its canonical security name directly matches this event's themes: equity. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- AIOO Allianzim U.S. Equity Buffer100 Protection Etf
Allianzim U.S. Equity Buffer100 Protection Etf (AIOO) is linked, with no stored direction, medium confidence in the 25 Sep 2026 story “Barclays Initiates Coverage of Ligand Pharmaceuticals Incorporated - Equity Right at Overweight.” Reason on file: GA selected AIOO as a RELATED security because its canonical security name directly matches this event's themes: equity. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- AJUL Innovator Equity Defined Protection Etf - 2 Yr To July 2026
In “Barclays Initiates Coverage of Ligand Pharmaceuticals Incorporated - Equity Right at Overweight,” Innovator Equity Defined Protection Etf - 2 Yr To July 2026 (AJUL) is linked, with no stored direction, medium confidence. Reason on file: GA selected AJUL as a RELATED security because its canonical security name directly matches this event's themes: equity. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- AVMC American Centy Etf Tr Avantis U S Mid Cap Equity Etf
American Centy Etf Tr Avantis U S Mid Cap Equity Etf (AVMC) is linked, with no stored direction, medium confidence in the 25 Sep 2026 story “Barclays Initiates Coverage of Ligand Pharmaceuticals Incorporated - Equity Right at Overweight.” Reason on file: GA selected AVMC as a RELATED security because its canonical security name directly matches this event's themes: equity. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BJUL Innovator U.S. Equity Buffer Etf - July
Innovator U.S. Equity Buffer Etf - July (BJUL) is linked, with no stored direction, medium confidence in the 25 Sep 2026 story “Barclays Initiates Coverage of Ligand Pharmaceuticals Incorporated - Equity Right at Overweight.” Reason on file: GA selected BJUL as a RELATED security because its canonical security name directly matches this event's themes: equity. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Barclays (BCS)
“Barclays Initiates Coverage of Ligand Pharmaceuticals Incorporated - Equity Right at Overweight” (25 Sep 2026) reaches Barclays (BCS) through this story.
The link for Barclays (BCS) is this: The reported development directly names BARCLAYS PLC in the headline; GA resolved that company to BCS
A second company, Wisdomtree Japan Hedged Equity Fd Etf (DXJ), is listed for a different reason: GA selected DXJ as a RELATED security because its canonical security name directly matches this event's themes: equity. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Price levels for Barclays (BCS)
AIEQ traded between 48.74 and 50.78 across 18 sessions. The latest close on file is 49.46. BCS traded between 22.07 and 25.41 across 20 sessions. The latest close on file is 22.17. DXJ traded between 59.28 and 184.61 across 20 sessions. The latest close on file is 59.91.
What the saved facts support for Barclays (BCS)
69 out of 100
“Barclays Initiates Coverage of Ligand Pharmaceuticals Incorporated - Equity Right at Overweight” scores 69 out of 100. The score uses 4 sources, and 7 linked companies.